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ABSTRACT 
OBJECTIVE: Because sex hormones may be involved in tumor initiation and progression, we analyzed the 
presence of hormone receptors in the transformation zone of the uterine cervix where the majority of human 
papillomavirus infections and associated (pre)neoplastic lesions develop. 
STUDY DESIGN: By using 23 total hysterectomy samples from young women who underwent surgery for 
noncervical benign uterine disease, we analyzed, by immunohistologic techniques, the in situ expression of 
estrogen (E2-R) and progesterone (P4-R) receptors in the transformation zone and ectocervix of the same women. 
RESULTS: The expression of estrogen receptors and progesterone receptors is significantly higher in the 
transformation zone compared with the ectocervix. Immunohistochemical localization indicated that hormone 
receptor-positive cells are mainly observed in (para)basal and intermediate cell layers in both the transformation 
zone and ectocervical epithelium. When transformation zone samples were segregated into epithelial tissues with 
a predominantly mature (7/23 samples) or immature (16/23 samples) squamous metaplasia, only biopsy 
specimens with immature squamous metaplasia showed a significantly higher density of hormone receptor-
positive cells compared with ectocervical epithelium (P < .01). 
CONCLUSION: Our results suggest that the cervical transformation zone may be at increased risk of the 
development of cancer because of a high sensitivity to sex hormone regulation. 
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A substantial majority of cancers and precursor lesions (squamous intraepithelial lesions; SILs) develop within a 
specific region of the cervix, the transformation zone (TZ),1 where the glandular epithelium of the endocervix is 
transformed progressively into a squamous epithelium during a process called metaplasia, which can be 
considered as a stepwise progression of changes. In the first phase, endocervical "reserve" cells proliferate and 
stratify.2 After, these cells differentiate into squamous cells that initially have only a slightly increased amount of 
cytoplasm and which undermine the endocervical epithelium that is often seen as a residual layer on the surface 
(immature squamous metaplasia). Later, the cells may mature fully to squamous cells that are indistinguishable 
from the superficial cells of the ectocervix.3 
The chronic infection of metaplastic keratinocytes of the TZ by oncogenic types of human papillomavirus (HPV) 
is associated with the induction of SIL, which may result in the development of cervical invasive cancer.4 
Despite the evidence that HPV is implicated strongly as the causative agent of cervical cancer, HPV infection 
alone is not sufficient for SIL development. In addition to immune, microbial, or chemical cofactors,5-7 sex 
hormones may play a role in the development of SIL. Indeed, the variation of hormonal status that depends on 
age, pregnancy, or contraceptive use, has been shown to influence the development of cervical (pre)neoplastic 
lesions.8-10 Interestingly, the topography and natural history of the cervical TZ are also affected by age, hormonal 
status, and parity.11 For example, the mechanism by which the original squamocolumnar junction changes 
location after the onset of puberty may be a mechanical one that is caused by the swelling of the cervical stroma 
in response to hormonal stimulation; pregnancy has been shown to be associated with more endocervical tissue 
moving out onto the ectocervix.3 Moreover, it has been demonstrated, in HPV16 transgenic mice models, that 
estrogen exposure is involved in the particular sensitivity of the TZ to SIL development.12,13 
These effects of sex hormones could be explained, in part, by their property to induce HPV gene expression 
through hormone response elements in the viral genome.14 Direct and indirect effects have been described 
previously.14,15 Accordingly, the expression of estrogen (E2-R) and progesterone (P4-R) receptors in human 
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cervical biopsy specimens has been shown to be higher in the stroma of low- and high-grade SIL, compared with 
normal ectocervix suggesting an indirect interaction between hormone receptors and HPV genome.15 However, 
the function of sex hormone receptors in neoplastic lesions of the cervix remains unclear. The positive rates of 
E2-R and P4-R were found to be lower in cervical invasive neoplasia15,16 and established squamous carcinoma of 
the cervix are not influenced markedly by steroids.17 
By using total hysterectomy samples from young women who underwent surgery for noncervical benign uterine 
disease, we analyzed, by immunohistologic techniques, the in situ expression of E2-R and P4-R in the TZ and 
ectocervix of the same women. Our results suggest that the TZ may be at increased risk of developing (pre)-
neoplastic lesions because of a high sensitivity to sex hormone regulation. 
MATERIAL AND METHODS 
Biopsy specimens.  
Twenty-three cervices from women who underwent total hysterectomy for noncervical benign uterine disease 
were analyzed in this study. These cases were retrieved from the files of the Pathology Department of University 
Hospital of Liège, Belgium, on the basis of histologic findings and a previous normal Papanicolaou test that was 
obtained shortly before surgery. Only paraffin blocks that showed histologic evidence of both ecto-cervical and 
TZ epithelium/stroma were selected. The TZ samples were divided into tissues with a predominantly mature 
(7/23 specimens, 30%) or immature (16/23 specimens, 70%) squamous metaplasia. 
The mean age of the women was 36.4 years (range, 30-41 years), and none of them were menopausal. The phase 
of menstrual cycle was determined systematically by endometrial histologic evidence and was categorized as 
either proliferative or secretory. 
Immunohistochemical staining of E2-R and P4-R.  
From paraffin-embedded biopsy specimens, sections (5-10 µm) were rehydrated, and endogenous peroxidase 
was blocked with 3% hydrogen peroxide in methanol for 10 minutes. The sections were then permeabilized with 
citric buffer and phosphate-buffered saline solution and 0.1% Tween for 20 minutes. The slides were incubated 
for 2 hours with mouse monoclonal to anti-human E2-R (clone 1D5, specific for the estrogen receptor a.) and P4-
R (clone PgR 636, specific for the α and β forms of progesterone receptor; Dako, Carpinteria, Calif). After being 
washed, the peroxidase-conjugated anti-mouse antibodies (Dako) were incubated for 30 minutes and visualized 
with diaminobenzidine (Dako) for 10 minutes. The reaction was stopped with distilled water, and slides were 
counter-stained with hematoxylin. 
Positive (from breast cancer biopsy specimens) and negative (irrelevant antibody; Dako) control slides were used 
for each immunohistochemical staining. 
Immunohistochemical staining of Ki-67 antigen.  
Five-micrometer sections of the biopsy specimens were deparaffinized, rehydrated, and incubated with 0.05% 
trypsin in TRIS-buffered saline solution (TBS) for 20 minutes at 37°C. After enzyme digestion, slides were 
rinsed in TBS. Antigen retrieval was then performed: the slides were treated for 15 minutes at 720 W in citrate 
buffer (10 mmol/L, pH 6.0) in a microwave oven. After being washed in TBS, sections were blocked with 
normal rabbit serum for 30 minutes and incubated at room temperature for 60 minutes with the MIB-1 
monoclonal antibody that is specific for Ki-67 antigen (Dako, Golstrup, Denmark) that was diluted 1:80 in TBS. 
The slides were then washed in TBS and incubated at room temperature for 30 minutes with a biotinylated rabbit 
anti-mouse monoclonal antibody (1:200; Dako). After another washing step, localization of the antibodies was 
performed with the avidin biotin complex method with alkaline phosphatase as enzyme (Dako) and new fuschin 
as chromogen. The sections finally were counterstained with hematoxylin and mounted for light microscopy. 
Evaluation of immunohistochemical staining.  
The immunostaining was evaluated by two independent observers with the Image Pro plus software (version 
4.5.0.19; Media Cybernetics Inc, Gleichen, Germany), which was found to be useful to divide off the fields and 
to tag the cells. Briefly, the percentages of positive cells in the TZ and ectocervical compartments were 
determined precisely by randomly selecting five fields in the epithelium and stroma of TZ and ectocervical 
regions and by counting 200 cells/field at x400 magnification. In epithelial fields, 200 cells that are in the whole 
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thickness of the squamous epithelium were designated as positive or negative, whereas the same number of cells 
was counted randomly in the subepithelial stroma. 
Statistical analysis.  
The nonparametric Mann-Whitney U test was used to compare labeled cells between the ectocervix and TZ with 
mature or immature squamous metaplasia; differences were considered to be significant at a probability value of 
<.05. 
RESULTS 
E2-R and P4-R expression in the TZ.  
Figs 1 and 2 show the percentages of E2-R and P4-R positive cells in the epithelium and stroma of ectocervix and 
TZ with mature and immature squamous metaplasia. A significantly higher expression of both receptors was 
observed in the epithelial (P < .01) and stromal (E2-R [P < .01 ]; P4-R [P < .05] ) compartments of TZ with 
immature squamous metaplasia compared with ectocervix (Figs 1, B, and 2, B). These differences were observed 
for each receptor, both in the proliferative and secretory phases of menstrual cycle (data not shown). The 
hormone receptor expression was not significantly different between the ectocervix and the TZ with mature 
metaplasia (Figs 1, A, and 2, A). 
 Immunohistochemical localization of E2-R (Fig 3, A and B) and P4-R (Fig 3, C and D) in the epithelial 
compartment indicated that labeled cells are observed mainly in (para) basal and intermediate cell layers in both 
TZ and ectocervical epithelial tissues. 
No absolute correlation between sex hormone receptor expression and cell proliferation.  
To determine whether sex hormone receptors are expressed predominantly in proliferating cells, we compared 
the localization of E2-R, P4-R, and Ki-67 positive cells in ectocervix and TZ biopsy specimens. Expression of Ki-
67 antigen was confined exclusively to the parabasal and basal cell layers of both ectocervical and metaplastic 
cervical epithelium, and no quantitative difference was observed between TZ and ectocervix (data not shown). 
Although E2-R and P4-R positive cells were detected in parabasal and basal cell layers, they were also 
demonstrated in intermediate cell layers in both localizations, which suggests the absence of an absolute 
correlation between steroid receptor expression and cell proliferation. 
 
Fig 1: Percentages of estrogen receptor positive cells in the epithelium and stroma of paired tissues of 
ectocervix (Ecto) and TZ with (A) mature (MM) and (B) immature (IM) squamous metaplasia. NS, Not 
significant; two asterisks, P < .01. 
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Fig 2: Percentages of progesterone receptor positive cells in the epithelium and stroma of paired tissues of 
ectocervix (Ecto) and TZ with (A) mature (MM) and (B) immature (IM) squamous metaplasia. NS, Not 




Several hypotheses have been proposed to explain the reason that cervical cancer, one of the most frequent 
causes of death in women worldwide,18 develops in the TZ of the uterine cervix, a small area of a few square 
millimeters. A first explanation for the increased sensitivity of the TZ to cervical (pre) neoplastic lesions is that 
the target cells for HPV infection, which presumably are present in the basal cell layers of the epithelium,6,19 may 
be mechanically more accessible in metaplastic areas in which monostratified glandular and pluristratified 
squamous epithelial tissues coexist ("mechanical accessibility" theory). Another possible explanation is that the 
keratinocytes of the TZ, because of their immature state, are deprived of a putative repression mechanism of the 
promoter of HPV oncogene expression. Accordingly, Sun et al20 showed that endocervical cells that were 
immortalized by HPV16 E6/E7 oncogenes form higher grade dysplasia in organotypic cultures than 
immortalized ectocervical keratinocytes. The inability of the cells that are derived from the TZ to control the 
viral oncogene expression could contribute to cervical neoplasia development and explain the reason that HPV-
associated lesions developed in the cervix, outside of the TZ, and elsewhere in the genital tract (eg, vagina, 
vulva) are less susceptible to progress to cancer than those lesions that develop in the TZ. Other endogenous 
factors might also be involved in the sensitivity of the TZ to SIL development. Using mice that are transgenic for 
HPV16, some investigators have shown that the TZ is five times more sensitive to the induction of squamous 
cell carcinogenesis by estrogen exposure compared with other sites of the reproductive tract.12 
In the current study, we have demonstrated, for the first time, a higher density of estrogen and progesterone 
receptor-positive cells in the epithelium and stroma of TZ with immature squamous metaplasia compared with 
ectocervix, which suggests that the TZ area in which the endocervical columnar epithelium is actively replaced 
by a pluristratified squamous epithelium has a higher sensitivity to sex hormone regulation. Our findings are in 
agreement with a recent study that shows that estrogens are involved directly in the process of squamous 
metaplasia in human TZ tissues that were implanted in mice with severe combined immunodeficiency13 These 
data, which are associated with the observation that the topography of the cervical TZ is also affected by the 
hormonal status of women,11 suggest that this region of the cervix may differ from the ectocervix in terms of sex 
hormone sensitivity. However, although endometrial expression of estrogen and progesterone receptors has been 
shown to vary during the menstrual cycle,21,22 no significant difference was demonstrated in hormone receptor-
positive cell density between the follicular and luteal phases in both TZ and ectocervical biopsy specimens. 
These data are in agreement with previous studies that show no significant variation, within the menstrual cycle, 
in hormone receptor concentrations in vaginal tissues23 and in HPV-associated lesions,15 which suggests a lower 
sensitivity to menstrual cycle changes of genital squamous mucosa compared with glandular endometrial tissues. 
Several studies have been performed previously with the objective to compare steroid hormone receptor 
expression between low/high-grade SIL and normal ectocervix.24-27 Despite some opposite results, it broadly 
appears that the expression of E2-R and P4-R is higher in SIL biopsies compared with normal ectocervix and 
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increases with the grade of SIL.15 For example, it has been reported that >60% of SIL biopsies express sex 
hormone receptors, strengthening the role of sex hormones in the development of SIL. 
Because the expression of proliferation-associated antigens (such as Ki-6728) also increases during the cervical 
carcinogenesis,29 we compared the localization of E2-R, P4-R, and Ki-67 positive cells in ectocervix and TZ 
biopsy specimens. As previously reported, the expression of Ki-67 antigen was confined exclusively to the 
parabasal and basal cell layers of ectocervical and metaplastic cervical epithelium,29 whereas E2-R and P4-R 
receptors were also detected in intermediate cell layers in both localizations, which suggests a lack of a strict 
correlation between steroid receptor expression and cell proliferation. Although the co-expression of sex 
hormone receptors and Ki-67 antigen has been reported in the cervix26 and in the endometrium,30 the correlation 
is not absolute, and cells in the quiescent GO phase of the cell cycle may also express E2 and P4 receptors. 
There are several potential mechanisms by which sex hormones may facilitate the cervical carcinogenesis. The 
first one results from the property of sex hormones to induce HPV gene expression directly and/or indirectly 
through steroid response elements in the viral genome.14,15 Interestingly, the expression of estrogen receptor and 
HPV oncogenes has been demonstrated in the same basal cell population,31 and several hypotheses have been 
proposed to explain how estrogen receptor-signaling pathways may synergize with the cellular effects of the 
HPV16 oncoproteins.12 In agreement with these data, hormone receptors were detected in basal and parabasal 
cells in TZ epithelium, in which the target cells for HPV infection are presumably present.6,19 
 
Fig 3: Immunohistochemical localization of estrogen (A and B) and progesterone (C and D) receptors in 
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In addition to interactions between sex hormones and HPV oncoproteins, it is also possible that hormones 
sensitize the TZ to cervical cancer formation by altering the local immune microenvironment. The squamous 
epithelium of the cervix is composed not only of keratinocytes (the primary target of HPV) but also of a type of 
immature dendritic cells, the Langerhans' cells, which are important for the immunosurveillance of the cervical 
epithelium.32 It has been demonstrated that the keratinocyte/dendritic cell interactions in the TZ play a key role in 
the establishment of SIL and, in particular, that the density of Langerhans cells is reduced significantly in TZ 
compared with ectocervix.29 The production of cytokines/chemokines is necessary to maintain a balanced 
turnover of Langerhans cells and is most likely influenced by the complex differentiation state of keratinocytes, 
which is altered in metaplastic areas of the TZ and during cervical carcinogenesis.33-35 Interestingly, sex 
hormones have been shown to be involved directly in the regulation of the production of cytokines/chemokines 
and to be able to influence the migration and/or functional capacity of Langerhans cells/dendritic cells.36,37 It is 
therefore possible that estrogen and progesterone are involved in the HPV-related development of SIL by 
altering the cytokine/ chemokine-dependent interactions between keratinocytes and Langerhans cells/dendritic 
cells. This hormonal influence could be marked particularly in the TZ because of higher expression of sex 
hormone receptor expression compared with ectocervix. This hypothesis is now under active investigation. 
In conclusion, our study demonstrated that estrogen and progesterone receptors are highly expressed in the TZ 
with immature squamous metaplasia compared with the ectocervix. This intrinsic feature of the TZ might 
explain partially the high susceptibility of this region to cervical HPV infections and associated (pre)neoplastic 
lesions and may be relevant for studies that aim to develop new antineoplastic or chemopreventive treatments. 
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